Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | FAAH | O00519 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.49 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.46 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.45 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.45 |
| ▸ | NAAA | Q02083 | 1/20 | 0.45 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.44 |
| ▸ | SELP | P16109 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL970600 | 0.94 | MEN1 (0.61) | MEN1KMT2AFAAHMAPK1HSP90AA1 | |
| SCHEMBL9633210 | 0.86 | FAAH (0.59) | MEN1KMT2AFAAHMAPK1HSP90AA1 | |
| SCHEMBL28881091 | 0.81 | FAAH (0.65) | MEN1KMT2AFAAHMAPK1HSP90AA1 | |
| SCHEMBL28881086 | 0.81 | FAAH (0.65) | MEN1KMT2AFAAHMAPK1HSP90AA1 | |
| SCHEMBL2146114 | 0.79 | FAAH (0.77) | MEN1KMT2AFAAHMAPK1HSP90AA1 | |
| SCHEMBL9003387 | 0.77 | NAAA (0.41) | MEN1KMT2AFAAHMAPK1NAAA | |
| SCHEMBL117494 | 0.77 | MEN1 (0.54) | MEN1KMT2AFAAHMAPK1HSP90AA1 | |
| SCHEMBL3868141 | 0.77 | MEN1 (0.54) | MEN1KMT2AFAAHMAPK1HSP90AA1 | |
| SCHEMBL115759 | 0.77 | MEN1 (0.54) | MEN1KMT2AFAAHMAPK1HSP90AA1 | |
| SCHEMBL114323 | 0.77 | MEN1 (0.54) | MEN1KMT2AFAAHMAPK1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | AVOCA LLC | 2011-01-27 | — | — | US | claimed |
| US-20080113892-A1 | Antimicrobial wash formulations including amidoamine-based cationic surfactants | SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT | 2008-05-15 | — | — | US | claimed |
| US-20020155962-A1 | Nonaqueous hair styling composition and method of use | ANDREW JERGENS COMPANY, THE | 2002-10-24 | — | — | US | claimed |
| US-11447640-B2 | Encapsulated materials with improved properties | SUN CHEMICAL CORPORATION (US) | 2022-09-20 | — | — | US | disclosed |
| EP-3500601-B1 | ENCAPSULATED MATERIALS WITH IMPROVED PROPERTIES | SUN CHEMICAL CORP (US) | 2021-07-28 | — | — | EP | disclosed |
| US-20210214561-A1 | ENCAPSULATED MATERIALS WITH IMPROVED PROPERTIES | SUN CHEMICAL CORPORATION (US) | 2021-07-15 | — | — | US | disclosed |
| EP-3500601-A1 | ENCAPSULATED MATERIALS WITH IMPROVED PROPERTIES | Sun Chemical Corporation (US) | 2019-06-26 | — | — | EP | disclosed |
| WO-2018035325-A1 | ENCAPSULATED MATERIALS WITH IMPROVED PROPERTIES | SUN CHEMICAL CORPORATION (US) | 2018-02-22 | — | — | WO | disclosed |
| US-8673272-B2 | Ultraviolet-absorbing compounds | ISP INVESTMENTS INC. (US) | 2014-03-18 | — | — | US | disclosed |
| US-8097602-B1 | Method of treating body insect infestation | HOST PHARMACEUTICALS, LLC (US) | 2012-01-17 | — | — | US | disclosed |
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | AVOCA LLC | 2011-01-27 | — | — | US | disclosed |
| US-6706674-B2 | CONTAINING A VINYL INTERPOLYMER SUCH AS A VINYL ACETATE-VINYL PYRROLIDONE COPOLYMER OR TERPOLYMER WITH VINYL PROPIONATE OR SODIUM ACRYLATE-VINYL ALCOHOL COPOLYMER | THE ANDREW JERGENS COMPANY | 2004-03-16 | — | — | US | disclosed |
| US-6642194-B2 | Clear hair shampoo composition comprising detersive component, emulsifier component and polysiloxane component in amount effective as hair conditioner | CHEMSIL SILICONES, INC. | 2003-11-04 | — | — | US | disclosed |
| US-6605577-B1 | Having a hindered amine group; hair shampoo | CHEMSIL SILICONES, INC. | 2003-08-12 | — | — | US | disclosed |
| US-20030134760-A1 | Clear conditioning detersive compositions and methods for making the same | CHEMSIL SILICONES, INC. | 2003-07-17 | — | — | US | disclosed |
| EP-1303260-A2 | LINKAGE OF AGENTS USING MICROPARTICLES | Pericor Science, Inc. (US) | 2003-04-23 | — | — | EP | disclosed |
| US-20020155962-A1 | Nonaqueous hair styling composition and method of use | ANDREW JERGENS COMPANY, THE | 2002-10-24 | — | — | US | disclosed |
| EP-1202706-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | Pericor Science, Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| WO-2002007707-A2 | LINKAGE OF AGENTS USING MICROPARTICLES | PERICOR SCIENCE, INC. (US) | 2002-01-31 | — | — | WO | disclosed |
| WO-2001007009-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | UFM1, UHRF1, CUTA | MEN1 284/4885KMT2A 756/4885FAAH 1423/4885 |
| US-20030134760-A1 | Clear conditioning detersive compositions and methods for making the same | ASH2L, CD47, THOC2 | MEN1 1630/4885KMT2A 90/4885FAAH 1378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.